Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Akero Therapeutics, Inc. (AKRO)

42.79
+0.77
+(1.83%)
At close: May 7 at 4:00:00 PM EDT
42.90
+0.11
+(0.26%)
Pre-Market: 8:54:08 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
285,423
285,423
172,870
115,156
100,886
Operating Income
-285,423
-285,423
-172,870
-115,156
-100,886
Net Non Operating Interest Income Expense
33,363
33,363
21,111
3,123
109
Other Income Expense
--
--
--
3,862
109
Pretax Income
-252,060
-252,060
-151,759
-112,033
-100,777
Net Income Common Stockholders
-252,060
-252,060
-151,759
-112,033
-100,777
Diluted NI Available to Com Stockholders
-252,060
-252,060
-151,759
-112,033
-100,777
Basic EPS
-3.75
--
-2.89
-2.87
-2.89
Diluted EPS
-3.75
--
-2.89
-2.87
-2.89
Basic Average Shares
67,136.77
--
52,568.16
38,984.77
34,827.39
Diluted Average Shares
67,136.77
--
52,568.16
38,984.77
34,827.39
Total Operating Income as Reported
-285,423
-285,423
-172,870
-115,156
-100,886
Total Expenses
285,423
285,423
172,870
115,156
100,886
Net Income from Continuing & Discontinued Operation
-252,060
-252,060
-151,759
-112,033
-100,777
Normalized Income
-252,060
-252,060
-151,759
-112,033
-100,777
Interest Income
38,031
38,031
24,210
3,862
109
Interest Expense
4,668
4,668
3,099
739
0
Net Interest Income
33,363
33,363
21,111
3,123
109
EBIT
-247,392
-247,392
-148,660
-111,294
-100,777
EBITDA
-247,374
-247,374
-148,631
-111,251
-100,736
Reconciled Depreciation
18
18
29
43
41
Net Income from Continuing Operation Net Minority Interest
-252,060
-252,060
-151,759
-112,033
-100,777
Normalized EBITDA
-247,374
-247,374
-148,631
-111,251
-100,736
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/20/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ETNB 89bio, Inc.
7.67
-1.03%
 
MDGL Madrigal Pharmaceuticals, Inc.
298.83
+1.25%
 
MLTX MoonLake Immunotherapeutics
37.60
-4.24%
 
BPMC Blueprint Medicines Corporation
99.80
+0.65%
 
APLS Apellis Pharmaceuticals, Inc.
17.99
-5.91%
 
IMVT Immunovant, Inc.
13.88
+0.29%
 
CRNX Crinetics Pharmaceuticals, Inc.
31.39
+2.85%
 
MRUS Merus N.V.
39.43
-0.04%
 
SRRK Scholar Rock Holding Corporation
29.70
+1.33%
 
RYTM Rhythm Pharmaceuticals, Inc.
64.63
+3.06%